에스바이오메딕스 / 2023.03.23 사업보고서
1. 요약재무정보
가. 연결 요약 재무제표
(주)에스바이오메딕스와 그 종속기업
(단위: 원)
구 분
제 19 기(당기)
제 18 기(전기)
제 17 기(전전기)
[유동자산]
11,201,111,000,000
14,341,894,000,000
14,321,770,000,000
ㆍ현금및현금성자산
4,065,825,000,000
6,131,389,000,000
9,188,378,000,000
ㆍ매출채권
1,246,330,000,000
388,802,000,000
713,768,000,000
ㆍ기타유동금융자산
2,640,212,000,000
6,817,081,000,000
3,075,944,000,000
ㆍ재고자산
1,569,964,000,000
763,735,000,000
707,716,000,000
ㆍ기타유동자산
671,982,000,000
227,905,000,000
342,956,000,000
[비유동자산]
13,156,714,000,000
3,453,876,000,000
3,743,330,000,000
ㆍ기타비유동금융자산
1,127,556,000,000
377,115,000,000
366,836,000,000
ㆍ유형자산
2,765,071,000,000
3,051,319,000,000
3,357,170,000,000
ㆍ무형자산
153,758,000,000
25,442,000,000
19,324,000,000
자산총계
24,357,825,000,000
17,795,770,000,000
18,065,100,000,000
[유동부채]
11,830,730,000,000
4,175,184,000,000
6,762,601,000,000
ㆍ기타유동금융부채
2,485,787,000,000
1,666,624,000,000
2,057,878,000,000
ㆍ기타유동부채
42,559,000,000
796,434,000,000
486,553,000,000
ㆍ단기차입금
8,288,261,000,000
2,006,160,000,000
3,610,325,000,000
ㆍ유동성장기차입금
331,660,000,000
96,015,000,000
88,944,000,000
ㆍ충당부채
252,830,000,000
65,865,000,000
13,465,000,000
[비유동부채]
11,492,066,000,000
9,788,972,000,000
6,502,801,000,000
ㆍ장기차입금
7,008,394,000,000
5,215,274,000,000
2,325,143,000,000
ㆍ기타비유동금융부채
785,153,000,000
956,328,000,000
809,932,000,000
ㆍ확정급여부채
1,600,499,000,000
1,369,579,000,000
1,119,409,000,000
ㆍ기타비유동부채
2,054,005,000,000
2,058,175,000,000
2,062,345,000,000
ㆍ비유동충당부채
44,015,000,000
189,616,000,000
185,972,000,000
부채총계
23,322,796,000,000
13,964,156,000,000
13,265,402,000,000
[지배기업의 소유주에게 귀속되는 자본]
(3,778,531,000,000)
2,510,343,000,000
5,816,378,000,000
ㆍ자본금
5,109,888,000,000
5,109,888,000,000
5,074,888,000,000
ㆍ자본잉여금
44,477,795,000,000
44,477,795,000,000
43,936,135,000,000
ㆍ결손금
(57,759,389,000,000)
(51,485,068,000,000)
(45,843,849,000,000)
[비지배지분]
4,813,560,000,000
1,321,270,000,000
(1,016,680,000,000)
자본총계
1,035,029,000,000
3,831,614,000,000
4,799,698,000,000
부채와 자본총계
24,357,825,000,000
17,795,770,000,000
18,065,100,000,000
매출액
12,112,652,000,000
8,868,223,000,000
5,319,321,000,000
영업손실
(3,748,043,000,000)
(4,626,035,000,000)
(8,433,101,000,000)
당기순손실
(4,755,031,000,000)
(5,242,118,000,000)
(8,589,832,000,000)
지배기업 소유주지분
(6,326,937,000,000)
(5,666,929,000,000)
(7,747,307,000,000)
비지배지분
1,571,906,000,000
424,811,000,000
(842,525,000,000)
기본 및 희석주당순이익(원)
(619)
(558)
(766)
연결에 포함된 회사수
1
1
1